Onapgo Injection, Solution
Product Images NDC 27505-006

Product Visual Gallery

This gallery contains 100 technical images submitted to the FDA as part of the official labeling for Onapgo (NDC 27505-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mdd Us Operations, Llc, A Subsidiary Of Supernus Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Onapgo 01)

Chemical structure of Apomorphine hydrochloride, showing the molecular framework of the active ingredient in ONAPGO 4.9 mg/mL injection solution.*

FDA Label Image

Figure 2 (Onapgo 02)

A line chart depicting changes from baseline in hours of ON time without troublesome dyskinesia and OFF time over 12 weeks of treatment with ONAPGO or placebo. The graph shows ONAPGO and placebo groups for both ON and OFF times, with numerical sample sizes noted for each week point.*

FDA Label Image

Figure 3 (Onapgo 03)

A bar chart comparing the percentage of subjects reporting various levels of improvement or worsening between ONAPGO injection (4.9 mg/mL) and placebo groups. Categories include Very Much Improved, Much Improved, Minimally Improved, No Change, Minimally Worse, Much Worse, and Very Much Worse, with percentages displayed for each group.*

FDA Label Image

Image (Onapgo 04)

ONAPGO 4.9 mg/mL injection, solution in a subcutaneous delivery device. The label shows the proprietary name ONAPGO and the generic name Apomorphine hydrochloride, with dosage strength 4.9 mg/mL. The device includes a digital control panel with buttons for dose, back, menu, and OK. Labeler is MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 05)

ONAPGO 4.9 mg/mL injection, solution in a clear vial with a blue and white label. The vial is intended for subcutaneous use and is labeled with the generic name Apomorphine hydrochloride. The product is distributed by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 05a)

ONAPGO injection, solution 4.9 mg/mL in a clear glass vial with a purple cap. The label shows the proprietary name ONAPGO and the active ingredient Apomorphine hydrochloride. The vial contains 3 mL of the solution and is manufactured by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 05b)

ONAPGO 4.9 mg/mL injection, solution in a subcutaneous injectable format. The packaging shows a single-dose vial with a purple cap and labeling that includes the proprietary name, concentration, and manufacturer MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 05c)

ONAPGO 4.9 mg/mL injection, solution for subcutaneous use in a 2 mL vial. The label shows the product name, active ingredient Apomorphine hydrochloride, concentration, and manufacturer: MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 05d)

ONAPGO 4.9 mg/mL Apomorphine hydrochloride injection solution in a single-dose vial. The label displays dosage concentration, product name, and manufacturer details, MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 05e)

ONAPGO 4.9 mg/mL injection, solution for subcutaneous use in a 3 mL glass vial with a purple cap and purple label text. The label includes the drug name, strength, route, and manufacturer: MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 05f)

ONAPGO 4.9 mg/mL injection, solution in a subcutaneous vial. The packaging displays the brand name ONAPGO prominently along with the active ingredient apomorphine hydrochloride. The label includes strength information and manufacturer details for MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 05g)

ONAPGO 4.9 mg/mL injection, solution in a 2 mL vial for subcutaneous use. The label includes the proprietary name ONAPGO and the active ingredient apomorphine hydrochloride. It is labeled by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc. The vial displays the product NDC 27505-006.*

FDA Label Image

Image (Onapgo 05h)

ONAPGO 4.9 mg/mL injection, solution for subcutaneous use in a 3 mL vial. The packaging is a rectangular box with blue and white colors. The labeler is MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 06)

FDA Label Image

Image (Onapgo 06a)

FDA Label Image

Image (Onapgo 06aa)

FDA Label Image

Image (Onapgo 06ab)

FDA Label Image

Image (Onapgo 06ac)

FDA Label Image

Image (Onapgo 06ad)

FDA Label Image

Image (Onapgo 06ae)

FDA Label Image

Image (Onapgo 06af)

FDA Label Image

Image (Onapgo 06ag)

FDA Label Image

Image (Onapgo 06ah)

FDA Label Image

Image (Onapgo 06ai)

FDA Label Image

Image (Onapgo 06aj)

FDA Label Image

Image (Onapgo 06ak)

FDA Label Image

Image (Onapgo 06al)

FDA Label Image

Image (Onapgo 06am)

FDA Label Image

Image (Onapgo 06an)

FDA Label Image

Image (Onapgo 06ao)

FDA Label Image

Image (Onapgo 06ap)

FDA Label Image

Image (Onapgo 06aq)

FDA Label Image

Image (Onapgo 06ar)

FDA Label Image

Image (Onapgo 06as)

FDA Label Image

Image (Onapgo 06at)

FDA Label Image

Image (Onapgo 06au)

FDA Label Image

Image (Onapgo 06av)

FDA Label Image

Image (Onapgo 06b)

FDA Label Image

Image (Onapgo 06c)

FDA Label Image

Image (Onapgo 06d)

FDA Label Image

Image (Onapgo 06e)

FDA Label Image

Image (Onapgo 06f)

FDA Label Image

Image (Onapgo 06g)

FDA Label Image

Image (Onapgo 06h)

FDA Label Image

Image (Onapgo 06i)

FDA Label Image

Image (Onapgo 06j)

FDA Label Image

Image (Onapgo 06k)

FDA Label Image

Image (Onapgo 06l)

FDA Label Image

Image (Onapgo 06m)

FDA Label Image

Image (Onapgo 06n)

FDA Label Image

Image (Onapgo 06o)

FDA Label Image

Image (Onapgo 06p)

FDA Label Image

Image (Onapgo 06q)

FDA Label Image

Image (Onapgo 06r)

FDA Label Image

Image (Onapgo 06s)

FDA Label Image

Image (Onapgo 06t)

FDA Label Image

Image (Onapgo 06u)

FDA Label Image

Image (Onapgo 06v)

FDA Label Image

Image (Onapgo 06w)

FDA Label Image

Image (Onapgo 06x)

FDA Label Image

Image (Onapgo 06y)

FDA Label Image

Image (Onapgo 06z)

FDA Label Image

Figure A (Onapgo 07)

Illustration of a medical infusion pump kit showing labeled components including a pump pouch, elastic belt, infusion pump device with display, spare CR123 battery, battery door key, and a lanyard, all contained within an open carrying case.*

FDA Label Image

Figure B (Onapgo 08)

Illustration of a subcutaneous injection device interface for ONAPGO (apomorphine hydrochloride) 4.9 mg/mL. The device features a display screen, multiple control buttons including arrows, menu, OK, and function keys, and ports for injection components labeled with letters a through j for user guidance.*

FDA Label Image

Figure D (Onapgo 09)

An instructional diagram showing a medication pen with a label indicating to use the battery drop key, with a pointer labeled 'k.' The image likely demonstrates a step in the device preparation or usage process.*

FDA Label Image

Figure C (Onapgo 10)

ONAPGO injection, solution 4.9 mg/mL, subcutaneous injection vial. The label shows the proprietary name ONAPGO, generic name Apomorphine hydrochloride, strength 4.9 mg/mL, and includes labeler information for MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc. Additional labeling details include lot number, expiration date, and handling instructions.*

FDA Label Image

Figure Co (Onapgo 100)

An instructional display panel showing a locked dose option symbolized by a lock icon next to a plus sign. Below, it indicates time remaining with placeholders for hours (XX hr) and minutes (XX min) followed by the word 'Remaining.' The design is monochromatic with white symbols and text on a black background.*

FDA Label Image

Figure Cp (Onapgo 101)

FDA Label Image

Figure Cq (Onapgo 102)

FDA Label Image

Figure Bd (Onapgo 103)

FDA Label Image

Figure Cs (Onapgo 104)

An instructional illustration showing a hand holding a digital device with a small screen and five buttons below it labeled with icons and text: a blue cross, a yellow warning triangle, MENU, and OK, suggesting user interaction with the device controls.*

FDA Label Image

Image (Onapgo 105)

ONAPGO 4.9 mg/mL injection, solution for subcutaneous use in a vial. The label shows the product name, strength, and dosage form. It includes usage and manufacturing details by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 105a)

ONAPGO 4.9 mg/mL injection, solution in a prefilled syringe for subcutaneous use. The vial label indicates apomorphine hydrochloride as the active ingredient. The label shows a clear syringe with measurement markings and includes manufacturer information: MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 105b)

ONAPGO 4.9 mg/mL injection, solution, is a subcutaneous prescription drug in a glass vial with a gray rubber stopper and black flip-off cap. The vial label includes the drug name, strength, and manufacturer MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Figure Ct (Onapgo 106)

An illustration of a handheld medical device with a digital screen and control buttons, used for administering subcutaneous injections. The device features two arrow buttons, a MENU button, a back/cancel button, and an OK button, with a finger pressing the back/cancel button. It has a clear cartridge on the left side for holding the injection solution.*

FDA Label Image

Figure Cu (Onapgo 107)

A digital display screen showing a dosing prompt with the question 'Dose?' and options 'No' and 'Yes,' where 'Yes' is highlighted in yellow. An 'EXIT' option is also displayed below.*

FDA Label Image

Figure Cw (Onapgo 108)

A black and white text panel showing a section titled 'Dose' with the phrase 'Delivering X.X mg' below it, indicating a dosage display or dosing information for a medication.*

FDA Label Image

Figure Cx (Onapgo 109)

An illustration showing the phrase 'Dose Delivered' along with a white medical cross symbol above the text and a green check mark below it, indicating successful dose delivery.*

FDA Label Image

Image (Onapgo 11)

ONAPGO 4.9 mg/mL Apomorphine hydrochloride subcutaneous injection solution. The image shows a vial's label featuring the product name, strength, dosage form, and administration route. The label includes a dose icon with a plus symbol and the word 'DOSE.' Labeler indicated as MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Figure Cy (Onapgo 110)

A black and white digital display panel indicating time remaining. It features symbols and placeholders for hours and minutes with the words 'Remaining' below, likely part of a device interface showing time left for a medication or infusion.*

FDA Label Image

Figure Cz (Onapgo 111)

An illustration showing a hand pressing the green 'OK' button on the control panel of a medical device. The device features a small screen and several buttons, including an up arrow, a down arrow, and two additional buttons labeled with icons. The design suggests a user interface for programming or operating an injection or delivery device.*

FDA Label Image

Figure Da (Onapgo 112)

A digital device screen displaying a simple menu interface with options: Pause, End, and Give + Dose. The Give + Dose option is highlighted in yellow, indicating selection. The display likely relates to administration or dosage control for a medication device.*

FDA Label Image

Figure Dc (Onapgo 113)

An electronic device display screen showing a prompt with the text 'Dose?' at the top, followed by options 'No' and 'Yes' with 'Yes' highlighted in yellow, and an 'EXIT' option on the bottom right. The interface suggests user input selection, possibly related to dosing decisions.*

FDA Label Image

Figure De (Onapgo 114)

A text panel showing dosing or timing instructions with symbols and placeholders: a plus sign next to 'X/X', followed by 'XXhr', a droplet symbol with 'XXmin', and the word 'Remaining' at the bottom. The exact numeric values are not specified.*

FDA Label Image

Figure Df (Onapgo 115)

This image shows a digital display screen with the text "+ Dose" at the top, and below it the status message "Locked" in red with a lock icon. Further text indicates the lock duration as "For Xhr XXmin," suggesting a timed lock or dose delay feature on a device.*

FDA Label Image

Figure Dg (Onapgo 116)

FDA Label Image

Figure Dh (Onapgo 116a)

Illustration of a handheld electronic device with a small screen and multiple buttons, including 'DOSE', 'MENU', and 'OK'. A hand is shown pressing the 'OK' button. The device appears to be used for dosage or medication management, likely related to the injection solution ONAPGO.*

FDA Label Image

Figure Dj (Onapgo 117)

An electronic device screen displaying a menu with four options: Pause (highlighted), End, Give + Dose, and a droplet icon at the top right corner. The screen is monochrome with white text on a black background and the Pause option is highlighted in yellow.*

FDA Label Image

Figure Dm (Onapgo 118)

An instructional illustration depicting how to open a container or vial. It shows a hand pinching and pulling to open a device, followed by lifting off the top part. It appears to guide users through a two-step opening process for a medical or pharmaceutical product.*

FDA Label Image

Figure Do (Onapgo 118b)

An illustration of a handheld medical device with a screen and buttons, including labeled buttons such as ON/OFF, MENU, and directional arrows. A hand is shown pressing the MENU button. The device appears designed for user interaction, potentially for administering or controlling medication delivery.*

FDA Label Image

Figure Dq (Onapgo 119)

FDA Label Image

Image (Onapgo 11a)

ONAPGO 4.9 mg/mL Apomorphine hydrochloride subcutaneous injection, solution label. The label includes dosage information and the product logo with a cross and the word 'DOSE'. The product is manufactured by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

FDA Label Image

Image (Onapgo 12)

FDA Label Image

Figure Ds (Onapgo 120)

An illustration displaying the message 'Infusion Resumed' along with a green checkmark symbol, indicating the continuation of infusion.*

FDA Label Image

Figure Du (Onapgo 120b)

An illustration showing a person holding a small electronic device with a display screen and four buttons labeled with icons for dose, inhale, menu, and OK. The device appears to be a dose delivery or monitoring device, related to subcutaneous injection treatment.*

FDA Label Image

Figure Dw (Onapgo 121)

FDA Label Image

Figure Dy (Onapgo 122)

A digital display screen showing a simple menu with options 'No' and 'Yes', where the 'Yes' option is highlighted in yellow. The words 'End' and 'EXIT' appear at the top and bottom corners respectively, suggesting a user interface for making a selection.*

FDA Label Image

Figure Ea (Onapgo 123)

An instructional image with text reading, 'STOP! Remove Line From Body Press OK,' with the last line highlighted in yellow. It appears to be a prompt or instruction related to product use.*

FDA Label Image

Figure Ed (Onapgo 124)

A digital display panel showing the message 'Please Wait Ending Infusion' in white text on a black background, indicating a pause or completion phase in an infusion process.*

FDA Label Image

Image (Onapgo 125)

ONAPGO 4.9 mg/mL injection solution in a vial for subcutaneous use. The label shows product and generic names (Apomorphine hydrochloride), strength, and vial quantity. Manufactured by MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.